Virtus ETF Advisers LLC Vaxart, Inc. Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $566 - $1,219	271 Added 0.73%	37,175 $81,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $5.28 $31,106 - $60,830	11,521 Added 45.39%	36,904 $129,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $6,435 - $9,960	-1,500 Reduced 5.58%	25,383 $128,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $14,725 - $20,313	2,552 Added 10.49%	26,883 $169,000
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $8,390 - $12,328	-1,258 Reduced 4.92%	24,331 $193,000
Q2 2021 Aug 10, 2021	SELL	$5.06 - $10.78 $67,439 - $143,675	-13,328 Reduced 34.25%	25,589 $192,000
Q1 2021 May 17, 2021	BUY	$5.64 - $23.33 $3,823 - $15,817	678 Added 1.77%	38,917 $235,000
Q4 2020 Feb 12, 2021	BUY	$3.5 - $7.98 $133,836 - $305,147	38,239 New	38,239 $218,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.